Qube Research & Technologies (QRT)’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.81M | Sell |
68,983
-274,428
| -80% | -$15.2M | ﹤0.01% | 1365 |
|
|
2025
Q1 | $16.6M | Buy |
343,411
+31,092
| +10% | +$1.5M | 0.02% | 618 |
|
|
2024
Q4 | $12.1M | Sell |
312,319
-10,670
| -3% | -$412K | 0.02% | 748 |
|
|
2024
Q3 | $14.5M | Sell |
322,989
-130,163
| -29% | -$5.86M | 0.02% | 604 |
|
|
2024
Q2 | $15.7M | Buy |
453,152
+390,997
| +629% | +$13.5M | 0.02% | 574 |
|
|
2024
Q1 | $1.8M | Buy |
+62,155
| New | +$1.8M | ﹤0.01% | 1555 |
|
|
2023
Q4 | – | Sell |
-91,735
| Closed | -$1.53M | – | 4137 |
|
|
2023
Q3 | $1.53M | Buy |
+91,735
| New | +$1.53M | ﹤0.01% | 1236 |
|
|
2023
Q1 | – | Sell |
-135,706
| Closed | -$1.48M | – | 2856 |
|
|
2022
Q4 | $1.48M | Buy |
135,706
+44,430
| +49% | +$485K | 0.01% | 989 |
|
|
2022
Q3 | $769K | Buy |
+91,276
| New | +$769K | ﹤0.01% | 1255 |
|
|
2021
Q2 | – | Sell |
-13,465
| Closed | -$349K | – | 2691 |
|
|
2021
Q1 | $349K | Buy |
+13,465
| New | +$349K | 0.01% | 1374 |
|